Small Volume Dissolution Testing as a Powerful Method during Pharmaceutical Development.

Standard compendia dissolution apparatus are the first choice for development of new dissolution methods. Nevertheless, limitations coming from the amount of material available, analytical sensitivity, lack of discrimination or biorelevance may warrant the use of non compendial methods. In this regard, the use of small volume dissolution methods offers strong advantages. The present study aims primarily to evaluate the dissolution performance of various drug products having different release mechanisms, using commercially available small volume USP2 dissolution equipment. The present series of tests indicate that the small volume dissolution is a useful tool for the characterization of immediate release drug product. Depending on the release mechanism, different speed factors are proposed to mimic common one liter vessel performance. In addition, by increasing the discriminating power of the dissolution method, it potentially improves know how about formulations and on typical events which are evaluated during pharmaceutical development such as ageing or scale-up. In this regard, small volume dissolution is a method of choice in case of screening for critical quality attributes of rapidly dissolving tablets, where it is often difficult to detect differences using standard working conditions.

[1]  Paul A. Dickinson,et al.  Clinical Relevance of Dissolution Testing in Quality by Design , 2008, The AAPS Journal.

[2]  A. Healy,et al.  Hydrodynamic simulation (computational fluid dynamics) of asymmetrically positioned tablets in the paddle dissolution apparatus: impact on dissolution rate and variability , 2005, The Journal of pharmacy and pharmacology.

[3]  S. Klein,et al.  The Mini Paddle Apparatus–a Useful Tool in the Early Developmental Stage? Experiences with Immediate-Release Dosage Forms , 2006 .

[4]  J. Crison,et al.  A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability , 1995, Pharmaceutical Research.

[5]  J. Gaddum,et al.  United States Pharmacopeia , 1955, Nature.

[6]  J. Dressman,et al.  Comparison of Drug Release From Metoprolol Modified Release Dosage Forms in Single Buffer versus a pH-Gradient Dissolution Test , 2006 .

[7]  A. Avdeef Solubility of sparingly-soluble ionizable drugs. , 2007, Advanced drug delivery reviews.

[8]  Jaber Emami,et al.  In vitro - in vivo correlation: from theory to applications. , 2006, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[9]  Alan Royce,et al.  In vivo and in vitro evaluation of three controlled release principles of 6-N-cyclohexyl-2'-O-methyladenosine. , 2004, Journal of controlled release : official journal of the Controlled Release Society.

[10]  K. Raghavan,et al.  Importance of using physiologically relevant volume of dissolution medium to correlate the oral exposure of formulations of BMS-480188 mesylate. , 2004, International journal of pharmaceutics.

[11]  Anne Marie Healy,et al.  Evaluation of hydrodynamics in the basket dissolution apparatus using computational fluid dynamics--dissolution rate implications. , 2006, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[12]  N. Kaniwa,et al.  Hydrodynamic Flows Around Tablets in Different Pharmacopeial Dissolution Tests , 2002, Drug Development and Industrial Pharmacy.

[13]  A. Noyes,et al.  The rate of solution of solid substances in their own solutions , 1897 .

[14]  Erika S. Stippler,et al.  The USP Performance Verification Test, Part I: USP Lot P Prednisone Tablets—Quality Attributes and Experimental Variables Contributing to Dissolution Variance , 2008, Pharmaceutical Research.

[15]  Kiyohiko Sugano,et al.  Oral Absorption of Poorly Water-Soluble Drugs: Computer Simulation of Fraction Absorbed in Humans from a Miniscale Dissolution Test , 2006, Pharmaceutical Research.